Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New Revision: v3.6.3 appears in the history, replacing the previous v3.6.2 entry. This signifies an update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-07-05T13:33:49.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the study record history. The older revision v3.6.0 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-06-28T08:22:16.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Recruitment status changed to 'No longer looking for participants,' indicating enrollment has ended. The record history now shows the latest revision as v3.6.0 and removes the earlier v3.5.5 entry from the history.
    Difference
    0.5%
    Check dated 2026-06-14T01:16:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the history, replacing the previous v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-06T20:55:27.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.5.4' was added to the study record history, replacing the previous 'Revision: v3.5.3'.
    Difference
    0.1%
    Check dated 2026-05-16T10:24:36.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A minor interface/version update is reflected by changing the displayed “Revision” from v3.5.2 to v3.5.3, without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T05:21:37.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.